用低剂量阿司匹林预防妊娠前:综合性审查
1Obstetrics and Gynaecology, Tongji University, Shanghai, CHN.
低剂量阿司匹林 (LDA) 显著降低了高风险怀孕中孕前和并发症的发生率. 这种安全,具有成本效益的干预措施可以在早期开始时改善孕产妇和胎儿的结果.
科学领域:
- 产科和妇科 产科和妇科
- 孕产妇和胎儿医学 孕产妇和胎儿医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 孕前 (PE) 是导致妊娠并发症的全球主要原因,其病理生理学不明.
- 不正常的胎盘,内皮功能障碍和免疫因素都会导致PE.
- 低剂量阿司匹林 (LDA) 是一种公认的高风险怀孕的预防治疗方法.
研究的目的:
- 审查低剂量阿司匹林 (LDA) 预防产前的疗效和安全性.
- 突出行动机制和最优的时间来启动LDA.
- 讨论PE预防的当前挑战和未来方向.
主要方法:
- 对LDA用于PE预防的大型临床试验和元分析的综述.
- 对LDA对循环氧化酶通路和血管功能的药理作用的分析.
- 关于最佳剂量,时间和坚持的证据的评估.
主要成果:
- 在怀孕16周之前开始的LDA显著减少了早期发病的PE和相关并发症,如FGR和早产.
- 这种LDA耐受性很好,对母亲或新生儿出血的风险很小.
- 有效剂量范围从每天60-150毫克,75毫克是常见的.
结论:
- LDA是一种具有成本效益的,以证据为基础的干预措施,用于减少产前的负担.
- 最佳的实施需要解决剂量标准化,遵守和可访问性.
- 未来的研究应侧重于生物标志物引导的查和个性化风险分层.
更多相关视频
10:28Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
05:31Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
Published on: January 26, 2024
相关概念视频
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Atherosclerosis III: Management
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Peripheral Artery Disease III: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
